Answers are grounded in this paper and cite their sources.
Cross-sectional study explores HRQOL in pediatric patients with β-thalassemia major, suggesting improvements.
Standardized treatment involving blood transfusion and iron chelation therapy in β-TM patients requires further enhancement. Additionally, improving nutritional status and preventing and treating comorbidities may benefit patients' HRQOL.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: